{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:08:16Z","timestamp":1790719696224,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.patbio.2010.01.011","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T10:49:03Z","timestamp":1269341343000},"page":"e69-e78","source":"Crossref","is-referenced-by-count":9,"title":["Int\u00e9r\u00eats des inhibiteurs de la neuraminidase dans la prise en charge des infections dues aux virus influenza"],"prefix":"10.1016","volume":"58","author":[{"given":"O.","family":"Ferraris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Escuret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bouscambert-Duchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Morfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2010.01.011_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.patbio.2010.01.011_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0006-3002(57)90389-X","article-title":"Neuraminidase: the specific enzyme of influenza virus and Vibrio\u00a0cholerae","volume":"23","author":"Gottschalk","year":"1957","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.patbio.2010.01.011_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/bj2070091","article-title":"Amino acid sequence of the Pronase-released heads of neuraminidase subtype N2 from the Asian strain A\/Tokyo\/3\/67 of influenza virus","volume":"207","author":"Ward","year":"1982","journal-title":"Biochem J"},{"key":"10.1016\/j.patbio.2010.01.011_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0042-6822(73)90457-1","article-title":"The size and shape of influenza virus neuraminidase","volume":"51","author":"Wrigley","year":"1973","journal-title":"Virology"},{"key":"10.1016\/j.patbio.2010.01.011_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2. 9 A resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.patbio.2010.01.011_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/prot.340060402","article-title":"The neuraminidase of influenza virus","volume":"6","author":"Air","year":"1989","journal-title":"Proteins"},{"key":"10.1016\/j.patbio.2010.01.011_bib7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/pro.5560031007","article-title":"Influenza virus neuraminidase: structure, antibodies, and inhibitors","volume":"3","author":"Colman","year":"1994","journal-title":"Protein Sci"},{"key":"10.1016\/j.patbio.2010.01.011_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubareva","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2010.01.011_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/viro.1993.1088","article-title":"Comparison of structure and sequence of influenza B\/Yamagata and B\/Beijing neuraminidases shows a conserved \u201chead\u201d but much greater variability in the \u201cstalk\u201d and NB protein","volume":"192","author":"Burmeister","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.patbio.2010.01.011_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","article-title":"Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase","volume":"6","author":"Varghese","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.patbio.2010.01.011_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/jm00031a011","article-title":"Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis","volume":"37","author":"Taylor","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.patbio.2010.01.011_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2. 2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid","volume":"11","author":"Burmeister","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.patbio.2010.01.011_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/pro.5560040606","article-title":"Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase","volume":"4","author":"Varghese","year":"1995","journal-title":"Protein Sci"},{"key":"10.1016\/j.patbio.2010.01.011_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.patbio.2010.01.011_bib16","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib18","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib19","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/AAC.42.12.3234","article-title":"Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071","volume":"42","author":"Tai","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkh528","article-title":"Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations","volume":"55","author":"Jackson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.patbio.2010.01.011_bib22","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/507559","article-title":"Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness","volume":"194","author":"Monto","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2003.11.008","article-title":"Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir","volume":"62","author":"Hurt","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2005.07.004","article-title":"Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice","volume":"68","author":"Ferraris","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib25","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.45.10.2723-2732.2001","article-title":"Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses","volume":"45","author":"Govorkova","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib26","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"Yen","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcv.2007.10.021","article-title":"Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors","volume":"41","author":"Richard","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib28","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1128\/JVI.76.11.5380-5386.2002","article-title":"In vitro selection and characterization of influenza A (A\/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675","volume":"76","author":"Molla","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-3542(01)00214-5","article-title":"Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets","volume":"54","author":"Herlocher","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.antiviral.2004.04.004","article-title":"In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors","volume":"63","author":"Cheam","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.patbio.2010.01.011_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.44.1.78-87.2000","article-title":"Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies","volume":"44","author":"Barnett","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/viro.1995.0058","article-title":"Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en","volume":"214","author":"Blick","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.patbio.2010.01.011_bib34","doi-asserted-by":"crossref","first-page":"b5106","DOI":"10.1136\/bmj.b5106","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis","volume":"339","author":"Jefferson","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.patbio.2010.01.011_bib35","doi-asserted-by":"crossref","first-page":"b3172","DOI":"10.1136\/bmj.b3172","article-title":"Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials","volume":"339","author":"Shun-Shin","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.patbio.2010.01.011_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2010.01.011_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib38","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/429241","article-title":"Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002\u20132003 influenza season","volume":"40","author":"Kawai","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib42","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group","volume":"343","author":"Hayden","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.282.1.31","article-title":"Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial","volume":"282","author":"Monto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/381128","article-title":"Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis","volume":"189","author":"Hayden","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib47","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario","volume":"45","author":"McGeer","year":"2007","journal-title":"Can Clin Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/135965350701200408","article-title":"Factors associated with early hospital discharge of adult influenza patients","volume":"12","author":"Lee","year":"2007","journal-title":"Antivir Ther (Lond)"},{"key":"10.1016\/j.patbio.2010.01.011_bib49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/600383","article-title":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza","volume":"200","author":"Lee","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib50","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib51","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2010.01.011_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.patbio.2010.01.011_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2010.01.011_bib54","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib55","article-title":"Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"25\u201328","author":"Escuret","year":"2008","journal-title":"J Clin Virol 41"},{"key":"10.1016\/j.patbio.2010.01.011_bib56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.081280","article-title":"Oseltamivir-resistant influenza virus A (H1N1). Europe, 2007\u201308 season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania. South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib58","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/JCM.02396-08","article-title":"Oseltamivir-resistant influenza a viruses circulating in Japan","volume":"47","author":"Tamura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.patbio.2010.01.011_bib59","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jmv.21546","article-title":"Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007\u20132008 season","volume":"81","author":"Ciblak","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1). Norway, 2007\u201308","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib61","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.05.19112-en","article-title":"Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses","volume":"14","author":"Kramarz","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.patbio.2010.01.011_bib62","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.46.19412-en","article-title":"Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses","volume":"14","author":"Ciancio","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.patbio.2010.01.011_bib63","unstructured":"World Health Organization. Seasonal influenza A(H1N1) virus resistant to oseltamivir. Available at http:\/\/www.who.int\/csr\/disease\/influenza\/2008-9NHemiResistanceTable2.pdf. Accessed on January 11, 2010."},{"key":"10.1016\/j.patbio.2010.01.011_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib65","unstructured":"World Health Organization. Avian influenza. Cumulative number of human cases of avian influenza. Available at: (http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2009_12_21\/en\/index.html\/. Accessed December 21, 2009."},{"key":"10.1016\/j.patbio.2010.01.011_bib66","unstructured":"World Health Organization. Avian influenza. Clinical management of human infection with avian influenza A(H5N1) virus. Available at: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/guidelines\/ClinicalManagement07.pdf\/. (August 15, 2007). Accessed December 21, 2009."},{"key":"10.1016\/j.patbio.2010.01.011_bib67","doi-asserted-by":"crossref","unstructured":"Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar, A., Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH et al. Update on avian influenza A (H5N1) virus infection in humans. N. Engl J Med 2008;358:261\u201373.","DOI":"10.1056\/NEJMra0707279"},{"key":"10.1016\/j.patbio.2010.01.011_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(08)61125-3","article-title":"Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series","volume":"372","author":"Kandun","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2010.01.011_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid1102.041061","article-title":"Human disease from influenza A (H5N1). Thailand, 2004","volume":"11","author":"Chotpitayasunondh","year":"2005","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib70","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib71","doi-asserted-by":"crossref","first-page":"e3410","DOI":"10.1371\/journal.pone.0003410","article-title":"Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza","volume":"3","author":"Taylor","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.patbio.2010.01.011_bib72","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.CCM.0000262940.34596.4B","article-title":"The critically ill avian influenza A (H5N1) patient","volume":"35","author":"Arabi","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib73","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial","volume":"355","author":"Nicholson","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.patbio.2010.01.011_bib74","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.00588-08","article-title":"Pharmacokinetics of high-dose oseltamivir in healthy volunteers","volume":"53","author":"Wattanagoon","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib75","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.01312-06","article-title":"Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus","volume":"51","author":"Govorkova","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib76","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/432008","article-title":"Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A\/Vietnam\/1203\/04 influenza virus in mice","volume":"192","author":"Yen","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib77","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.05.012","article-title":"Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice","volume":"80","author":"Boltz","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2008.06.014","article-title":"Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques","volume":"80","author":"Stittelaar","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.patbio.2010.01.011_bib79","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/JVI.02174-08","article-title":"Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding","volume":"83","author":"Van Hoeven","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib80","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1128\/JVI.02144-08","article-title":"Early control of H5N1 influenza virus replication by the type I interferon response in mice","volume":"83","author":"Szretter","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir Ther (Lond)"},{"key":"10.1016\/j.patbio.2010.01.011_bib82","doi-asserted-by":"crossref","first-page":"e1000091","DOI":"10.1371\/journal.pmed.1000091","article-title":"What is the optimal therapy for patients with H5N1 influenza?","volume":"6","author":"White","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib83","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/AAC.01579-07","article-title":"Oseltamivir\u2013ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice","volume":"52","author":"Ilyushina","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib84","unstructured":"World Health Organization. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. Available at: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/guidelines\/nomenclature\/en\/index.html. Accessed May 12, 2009."},{"key":"10.1016\/j.patbio.2010.01.011_bib85","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance--disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib86","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.patbio.2010.01.011_bib87","series-title":"Options for the Control of Influenza VI June 17\u201323, 2007 Toronto","article-title":"Detection of oseltamivir resistance mutation N294S in humans with influenza A H5N1","author":"Saad","year":"2007"},{"key":"10.1016\/j.patbio.2010.01.011_bib88","doi-asserted-by":"crossref","first-page":"e3339","DOI":"10.1371\/journal.pone.0003339","article-title":"Influenza A H5N1 clade 2. 3. 4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam","volume":"3","author":"Le","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.patbio.2010.01.011_bib89","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.33.19309-en","article-title":"epidemic intelligence team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009","volume":"14","author":"Vaillant","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.patbio.2010.01.011_bib90","unstructured":"Centers for Disease Control and Prevention (CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:433\u20135."},{"key":"10.1016\/j.patbio.2010.01.011_bib91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-7-73","article-title":"Postexposure prophylaxis during pandemic outbreaks","volume":"7","author":"Moghadas","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib92","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source","volume":"309","author":"Longini","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.patbio.2010.01.011_bib93","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3201\/eid1512.091062","article-title":"Respiratory disease in adults during pandemic (H1N1) 2009 outbreak, Argentina","volume":"15","author":"Zala","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib94","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April\u2013June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib95","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.44.19389-en","article-title":"Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April \u2013 3 October 2009","volume":"14","author":"Cullen","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.patbio.2010.01.011_bib96","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2009.1536","article-title":"Critically Ill patients with 2009 influenza A(H1N1) in Mexico","volume":"302","author":"Dom\u00ednguez-Cherit","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.patbio.2010.01.011_bib97","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. Cas graves de grippe A(H1N1)v. Available at http:\/\/www.afssaps.fr\/Dossiers-thematiques\/Pandemie-grippale\/Cas-graves-de-grippe-A-H1N1-v\/(offset)\/4. Accessed January 11, 2011."},{"key":"10.1016\/j.patbio.2010.01.011_bib98","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1399-3062.2008.00362.x","article-title":"Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Khanna","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib99","article-title":"Guidance on novel influenza A\/H1N1 in solid organ transplant recipients","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.patbio.2010.01.011_bib100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1503\/cmaj.090866","article-title":"Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women","volume":"181","author":"Tanaka","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.patbio.2010.01.011_bib101","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3810\/pgm.2009.11.2080","article-title":"Novel H1N1 virus infection and pregnancy","volume":"121","author":"Satpathy","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib102","unstructured":"Institut national de veille sanitaire. Cas group\u00e9s de A(H1N1)2009 r\u00e9sistant \u00e0 l\u2019oseltamivir. Available at http:\/\/www.invs.sante.fr\/international\/notes\/cas_groupes_A(H1N1)2009_resistant_oseltamivir_251109.pdf. Accessed January 11, 2010."},{"key":"10.1016\/j.patbio.2010.01.011_bib103","unstructured":"World Health Organization. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Weekly Epidemiol Rec no. 44, 2009; 84:453\u2013468. Available at http:\/\/www.who.int\/wer\/2009\/wer8444.pdf. Accessed January 11, 2010."},{"key":"10.1016\/j.patbio.2010.01.011_bib104","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcv.2009.08.004","article-title":"Detection of an oseltamivir-resistant pandemic influenza A\/H1N1 virus in Hong Kong","volume":"46","author":"Leung","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.patbio.2010.01.011_bib105","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3201\/eid1512.091057","article-title":"Oseltamivir-resistant influenza a pandemic (H1N1) 2009 virus, Hong Kong","volume":"15","author":"Chen","year":"2009","journal-title":"China Emerging Infect Dis"},{"key":"10.1016\/j.patbio.2010.01.011_bib106","unstructured":"World Health Organization. Viruses resistant to oseltamivir (Tamiflu) identified. Available at http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_antiviral_resistance_20090708\/en\/. Accessed January 11, 2010."},{"key":"10.1016\/j.patbio.2010.01.011_bib107","doi-asserted-by":"crossref","first-page":"b4975","DOI":"10.1136\/bmj.b4975","article-title":"First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales","volume":"339","author":"Gulland","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.patbio.2010.01.011_bib108","article-title":"Influenza pathogenesis: Lessons earned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza","author":"Meunier","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.patbio.2010.01.011_bib109","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.patbio.2010.01.011_bib111","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811410000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811410000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T05:04:27Z","timestamp":1685509467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811410000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0369811410000325"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2010.01.011","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}